Show MeYes, orchitis can cause infertility, but most men who get it do not become infertile. The risk rises when inflammation is severe, bilateral, untreated, or caused by mumps after puberty. Orchitis damages seminiferous tubules, disrupts the blood-testis barrier, and can trigger testicular atrophy, which reduces sperm production. Bacterial epididymo-orchitis is less likely to cause permanent infertility when treated promptly. Fertility usually recovers within 3 to 6 months because sperm production takes about 74 days plus transit. Persistent low sperm counts or testicular shrinkage after 6 to 12 months warrants a semen analysis and specialist evaluation.
Mechanisms: How Orchitis Injures Sperm-Producing Tissue
Orchitis is inflammation of the testis. It often occurs with epididymitis, which is inflammation of the coiled tube behind the testis. Sperm production happens inside the seminiferous tubules, where Sertoli cells nurse developing sperm and Leydig cells make testosterone. The testis also has a blood-testis barrier, a tight physical and immune barrier that normally protects sperm from the body’s immune system.
Acute orchitis changes that environment fast. Infection or immune injury brings neutrophils and lymphocytes into the testis. Those cells release cytokines such as interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha. They also produce reactive oxygen species. Swelling raises pressure inside the tight fibrous capsule of the testis. The blood-testis barrier can become leaky, exposing sperm antigens to immune cells and sometimes triggering anti-sperm antibodies.
The timing matters because sperm production is slow. A full spermatogenesis cycle takes about 74 days. Sperm then spend roughly 10 to 14 days transiting the epididymis. That means an injury today may not show up in a semen analysis for about 3 months. A fever above 38.5°C can also transiently suppress sperm production for 2 to 3 months, even without direct testicular infection.
Permanent damage comes through fibrosis and tubular loss. If inflammation destroys seminiferous tubules, the testis cannot make sperm efficiently. The testis may shrink, a condition called testicular atrophy. Leydig cells are more resistant than sperm-producing cells, so testosterone often remains normal. In severe bilateral cases, hormone dysfunction can occur, but it is less common than impaired sperm production.
In plain terms: orchitis is dangerous to fertility when it damages enough sperm-producing tissue in both testes, or when it causes persistent obstruction or atrophy.
Fertility Risk: Can Orchitis Cause Infertility?
Can orchitis cause infertility in every case? No. The risk depends on the cause, whether one or both testes are involved, how severe the inflammation is, how quickly treatment starts, and the man’s baseline fertility. A mild unilateral case is very different from bilateral mumps orchitis with atrophy.
Mumps is the best-known cause. After puberty, mumps orchitis develops in roughly 20% to 30% of infected males. Bilateral involvement occurs in about 10% to 30% of mumps orchitis cases. Testicular atrophy follows in roughly 30% to 50% of affected testes. Older landmark data, including the Beard et al., 1977 series, suggested permanent infertility in about 13% of men after bilateral mumps orchitis. Unilateral disease carries a much lower risk.
Bacterial epididymo-orchitis is usually unilateral. Prompt antibiotics reduce the chance of abscess, obstruction, and permanent testicular damage. The CDC 2021 STI treatment guidelines recommend pathogen-directed antibiotics when sexually transmitted bacteria are suspected. Infertility after adequately treated bacterial disease is uncommon, but it is not zero. Delayed treatment, abscess formation, and bilateral obstruction are the main routes to persistent fertility problems.
Non-mumps viral orchitis is less studied. Most cases are self-limited, and bilateral involvement is uncommon. SARS-CoV-2 has been reported to affect testicular tissue, but cause-and-effect infertility risk remains unproven. Semen changes after acute viral illness are often transient.
Semen numbers help quantify risk, but they do not define infertility alone. The 2021 WHO laboratory manual lists lower reference limits of 1.4 mL volume, 16 million sperm per mL, 39 million total sperm, 42% total motility, and 4% normal morphology. A value below one of those limits is not automatically infertility. Infertility is a couple-level outcome, usually defined after 12 months of unprotected intercourse without conception.
Can orchitis cause infertility after a single mild episode? Usually no. The higher-risk pattern is bilateral disease, marked atrophy, persistent azoospermia, or repeated abnormal semen analyses after adequate recovery time. Whether orchitis can cause infertility is therefore a cause-specific question, not a yes-or-no label for every case.
Recovery Timeline: Sperm, Hormones, and Atrophy
Most men recover sperm production after orchitis, but recovery is not linear. The first days are about controlling inflammation and ruling out torsion or abscess. The first months are about waiting for the slow sperm-production cycle to restart. The table below gives practical timing.
| Time after orchitis | What is happening | What testing can show | Practical meaning |
|---|---|---|---|
| 0 to 7 days | Acute inflammation, swelling, pain, possible fever | Physical exam and ultrasound if torsion is suspected | Treat the cause and rule out emergencies |
| 1 to 4 weeks | Edema and immune activation begin to settle | Semen analysis is unreliable for fertility | Do not judge fertility yet |
| 6 to 12 weeks | Early spermatogenesis recovery | A 3-month semen analysis may be reasonable if disease was bilateral or severe | One abnormal result is not final |
| 3 to 6 months | Most sperm recovery occurs | Repeat semen analysis if the first test was abnormal | This is the main surveillance window |
| 6 to 12 months | Persistent low count or atrophy becomes clearer | FSH, testosterone, and repeat semen analysis | Specialist referral is reasonable if abnormalities persist |
| 12 to 24 months | Outcome is usually stable | Fertility evaluation and treatment planning | Assisted reproduction may be discussed |
| After 24 months | Little further spontaneous recovery is expected | Confirm persistent azoospermia or severe oligospermia | Focus on fertility treatment options |
FSH is useful because it rises when Sertoli cell and tubular function fail. Testosterone often stays normal because Leydig cells are less vulnerable. Ultrasound evidence of atrophy does not prove infertility by itself. A normal semen analysis at 3 months is reassuring. A low count at 3 months should usually be repeated at 6 months before drawing conclusions.
In plain terms: the 3-month test checks the first wave of recovered sperm, and the 6-month test shows whether a problem is persistent.
Edge Cases: Bilateral Orchitis, Atrophy, and Age
Bilateral orchitis is the strongest fertility risk factor. Two affected testes mean less reserve for sperm production. Bilateral mumps orchitis with atrophy is the classic high-risk scenario. For context, normal adult testicular volume is about 15 to 25 mL, borderline atrophy is 12 to 15 mL, and marked atrophy is below 12 mL. A man with bilateral marked atrophy and a very low sperm count has a much higher chance of persistent infertility than a man with one normal-sized testis.
Age at infection matters. Mumps orchitis is uncommon before puberty because the prepubertal testis is less active. Postpubertal and adult testes are more vulnerable. Older age does not automatically worsen orchitis, but baseline fertility and partner age affect how quickly a couple should seek help.
Abscess and obstruction are uncommon but important. A bacterial abscess can destroy testicular tissue if not drained. Bilateral epididymal obstruction can cause azoospermia even when sperm production is intact. Granulomatous orchitis is rare and can mimic testicular cancer, so persistent firm swelling needs urology assessment.
SARS-CoV-2 and other emerging infections deserve caution, not panic. Testicular viral detection has been reported, but robust evidence that these infections cause permanent male infertility is lacking. The same principle applies to anti-sperm antibodies after barrier disruption: they are found in some men after orchitis, but their presence does not automatically prove infertility.
Misconceptions: Fever, Testosterone, and One Bad Semen Test
Fever alone does not cause permanent infertility. Any significant febrile illness can lower sperm counts for 2 to 3 months because developing sperm are heat-sensitive. The effect is usually temporary. Persistent abnormalities need repeat testing and a search for atrophy, obstruction, or another cause.
One abnormal semen analysis does not mean a man is infertile. Sperm counts vary between samples, often by 10% to 30% or more. A low result should be repeated after 4 to 12 weeks, especially if the first sample was collected during illness or shortly after orchitis.
Testosterone supplements do not improve fertility. Exogenous testosterone suppresses the pituitary signal to the testes and can drop sperm production to zero within 3 to 6 months. This is a common and correctable mistake. Men with orchitis-related low sperm counts should not start testosterone for fertility purposes without specialist input.
Antibiotics do not treat mumps orchitis because mumps is viral. Corticosteroids are sometimes used for severe inflammation, but evidence that they prevent infertility is weak. Anti-sperm antibodies are not an automatic infertility diagnosis. They can coexist with normal fertility, and treatment decisions should not rest on antibody testing alone.
What to Actually Do: Fertility-Preserving Steps
Acute scrotal pain needs prompt evaluation. Sudden severe testicular pain can be torsion, which threatens the testis within hours. Bacterial epididymo-orchitis should be treated with appropriate antibiotics per the CDC 2021 STI treatment guidelines when sexually transmitted pathogens are suspected. Complete the full course and arrange follow-up if swelling or pain persists.
Supportive care matters for comfort and possibly for recovery. Scrotal elevation and ice for 15 to 20 minutes every 2 to 4 hours during the first 48 hours can reduce swelling. Avoid prolonged heat exposure, hot tubs, and strenuous activity for 1 to 2 weeks. Nonsteroidal anti-inflammatory drugs can help pain if there is no contraindication.
Fertility surveillance should be timed rationally. Get a semen analysis at 3 months if orchitis was bilateral, severe, or associated with atrophy. Repeat it at 6 months if abnormal. The 3-month and 6-month checks are surveillance intervals, not the 12-month definition of infertility. A couple meets the clinical definition after 12 months of unprotected intercourse, or after 6 months if the female partner is 35 or older.
| Semen analysis timing | Best use | Limitation | Next step |
|---|---|---|---|
| 4 to 6 weeks | Only for persistent symptoms or suspected recurrence | Too early to judge fertility | Treat symptoms and retest later |
| 3 months | First fertility check after moderate or severe orchitis | May be early for slow recoverers | Repeat at 6 months if abnormal |
| 6 months | Confirms whether abnormalities persist | Delays specialist care for some men | See a fertility specialist if still abnormal |
| 12 months | Aligns with the clinical infertility definition | May delay treatment for high-risk men | Start formal infertility evaluation |
Seek emergency care for these red flags:
- Sudden severe testicular pain, especially with nausea or vomiting
- A high-riding testis or absent cremasteric reflex
- Fever above 38.5°C with scrotal swelling, redness, or severe tenderness
- Signs of abscess, such as fluctuance, skin necrosis, or worsening pain
- Rapidly enlarging scrotum or difficulty urinating
- Persistent azoospermia or bilateral atrophy at 6 to 12 months
Limits of the Evidence and Specialist Referral
Much of the mumps orchitis literature is old, hospital-based, and small. Some studies predate widespread vaccination, so their fertility rates may not apply to current populations. Bacterial orchitis studies rarely follow men long enough to measure live birth outcomes. Infertility is also a couple-level diagnosis, which means a man’s semen result is only part of the picture.
The 2020 AUA/ASRM male infertility guideline supports evaluation after 12 months of unprotected intercourse without conception. Earlier evaluation is reasonable with known risk factors such as bilateral atrophy, prior orchitis with persistent azoospermia, abnormal FSH, or abnormal testosterone. A specialist can assess varicocele, obstruction, hormonal dysfunction, and assisted reproduction options.
No randomized trial has proven that any drug prevents infertility after mumps orchitis. Steroids, interferon, and other immune-modulating treatments have been studied or used anecdotally, but strong evidence is lacking. The practical question is not whether orchitis can cause infertility in theory. It is whether this man has persistent bilateral atrophy and abnormal semen parameters after adequate recovery time.